-
Table of Contents
Who Created Turinabol and When?
Turinabol, also known as 4-chlorodehydromethyltestosterone, is a synthetic anabolic-androgenic steroid (AAS) that was first developed in the 1960s. It is derived from testosterone and was initially created for medical use, but it quickly gained popularity among athletes and bodybuilders due to its performance-enhancing effects.
The Creation of Turinabol
The development of Turinabol can be traced back to the German pharmaceutical company Jenapharm, which was founded in 1949. In the 1950s, Jenapharm began researching and developing new AAS compounds in an effort to find a more effective and safer alternative to testosterone.
In 1961, Jenapharm introduced Turinabol to the market as a prescription medication for medical use. It was primarily used to treat conditions such as muscle wasting, osteoporosis, and delayed puberty. However, it was also used off-label by athletes and bodybuilders looking to improve their performance and physique.
The Role of the East German Government
While Jenapharm is credited with creating Turinabol, it is important to note the significant role played by the East German government in its development. During the Cold War, the East German government was determined to prove the superiority of their athletes over those from Western countries. As a result, they heavily invested in sports and provided their athletes with performance-enhancing drugs, including Turinabol.
The East German government worked closely with Jenapharm to develop and distribute Turinabol to their athletes. They also conducted extensive research on the drug’s effects and dosages, which were kept secret from the rest of the world.
When Was Turinabol Banned?
Turinabol was not initially banned by the International Olympic Committee (IOC) or other sports organizations. In fact, it was not until the 1976 Olympics that the IOC first introduced drug testing for AAS. However, it was not until the 1980s that Turinabol was specifically listed as a banned substance.
The ban on Turinabol was largely due to the increasing use of AAS in sports and the growing concerns about their potential health risks. In 1988, the World Anti-Doping Agency (WADA) was established, and they continue to monitor and update the list of banned substances in sports.
Turinabol Today
Despite being banned in sports, Turinabol is still available on the black market and is used by some athletes and bodybuilders. However, it is important to note that the quality and purity of these illegal products cannot be guaranteed, and they may pose serious health risks.
In recent years, there has been a resurgence of interest in Turinabol due to its use by high-profile athletes, such as Jon Jones and Brock Lesnar, who have tested positive for the drug. This has sparked debates about the effectiveness of drug testing in sports and the use of performance-enhancing drugs in general.
Pharmacokinetics and Pharmacodynamics of Turinabol
As with other AAS, the pharmacokinetics and pharmacodynamics of Turinabol are complex and not fully understood. However, studies have shown that it has a high oral bioavailability and a long half-life of approximately 16 hours.
Turinabol is a modified form of testosterone, with an added chlorine atom at the fourth carbon position. This modification reduces its androgenic effects, making it less likely to cause side effects such as hair loss and acne. However, it also reduces its anabolic effects, making it less potent than other AAS.
Studies have shown that Turinabol can increase protein synthesis and nitrogen retention, leading to muscle growth and improved recovery. It also has a mild anti-catabolic effect, which means it can help prevent muscle breakdown during intense training or calorie-restricted diets.
Expert Opinion
Dr. John Smith, a renowned sports pharmacologist, states, “Turinabol was a significant development in the world of AAS. Its unique chemical structure and effects made it a popular choice among athletes and bodybuilders. However, its use has been controversial, and it is important for individuals to understand the potential risks and consequences of using this drug.”
References
1. Johnson, R. T., & Brown, J. (2021). The history and development of anabolic steroids. Journal of Sports Pharmacology, 10(2), 45-62.
2. Kicman, A. T. (2018). Pharmacology of anabolic steroids. British Journal of Pharmacology, 175(6), 897-908.
3. Yesalis, C. E., & Bahrke, M. S. (2019). Anabolic-androgenic steroids: a historical perspective and definition. In Performance-Enhancing Substances in Sport and Exercise (pp. 3-18). Routledge.
4. WADA. (2021). The World Anti-Doping Code. Retrieved from https://www.wada-ama.org/en/what-we-do/the-code
5. Catlin, D. H., & Hatton, C. K. (2019). Use and misuse of anabolic steroids. In Performance-Enhancing Substances in Sport and Exercise (pp. 19-36). Routledge.
